Townsquare Capital LLC Sorrento Therapeutics, Inc. Transaction History

Townsquare Capital LLC

  • $8.15 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$4.65 - $7.23 $59,357 - $92,290
-12,765 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.03 - $16.51 $703 - $1,651
100 Added 0.79%
12,765 $106,000
Q3 2020

Dec 01, 2020
SELL
$6.17 - $18.82 $1,234 - $3,764
-200 Reduced 1.55%
12,665 $134,000
Q2 2020

Aug 17, 2020
BUY
$1.73 - $6.76 $22,256 - $86,967
12,865 New
12,865 $99,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email